MUMBAI: The Indian pharmaceutical industry just got a major upgrade! The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has named Bhavin Mukund Mehta, Kilitch Drugs (India) Limited wholetime director, as its new vice-chairman. With over 25 years of industry experience, Mehta’s leadership is set to supercharge India’s global pharmaceutical exports.

A deal-making, strategy-shaping, market-expanding powerhouse, Mehta has not only catapulted Kilitch Drugs onto the global stage but also reinforced its domestic stronghold. Now, at Pharmexcil, he’s gearing up to break new ground, fuel innovation, and champion MSMEs—because, let’s face it, even the biggest industry players were once small businesses with big dreams.

Mehta’s association with Pharmexcil isn’t new—he’s practically been its MVP for years. Back in 2012, he was appointed as the chairman of the Exhibition Committee by the Ministry of Commerce, where he didn’t just organise trade events—he launched IPHEX, India’s largest pharmaceutical export exhibition, proving that India’s pharma game isn’t just strong, it’s global.

From negotiating high-stakes trade deals to ensuring Indian pharma gets its well-deserved global spotlight, Mehta has been the industry’s go-to expert. His latest appointment as vice-chairman of Pharmexcil? Just the logical next step in his mission to put Indian pharma on every international shelf possible.

Expressing his gratitude, Mehta said, "I am truly honoured to be appointed as vice-chairman at Pharmexcil. While promoting the growth of pharmaceutical exports, I am also committed to promoting the growth of MSMEs within India’s pharmaceutical sector, which plays a vital role in enhancing global health. Together, we will work to unlock new opportunities, drive innovation, and strengthen India’s position as a leader in pharmaceutical exports worldwide.”

Mehta isn’t just about business—he’s got the credentials to back it up. He holds a post graduate diploma in management from S.P. Jain Institute of Management, Mumbai, and a bachelor of pharmaceutical sciences from the University of Mumbai. His unique blend of technical knowledge and business acumen has been instrumental in navigating regulatory landscapes, executing expansion strategies, and driving pharmaceutical innovations.

With his appointment, Pharmexcil is set for a dynamic shift, championing not just large-scale pharma players but also boosting MSMEs that form the backbone of India’s pharmaceutical ecosystem.